C. Na nakorn

Association between polymorphisms of LEP, LEPR, DRD2, HTR2A and HTR2C genes and risperidone- or clozapine-induced hyperglycemia

C. Sukasem, A. Puangpetch, M. Kroll, 2019, Pharmacogenomics and personalized medicine.

Genetic Variations and Frequencies of the Two Functional Single Nucleotide Polymorphisms of SLCO1B1 in the Thai Population

C. Sukasem, C. Dejthevaporn, P. Srisawasdi, 2020, Frontiers in Pharmacology.

Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia

C. Sukasem, Y. Vorasettakarnkij, Sadeep Medhasi, 2022, Pharmacogenomics and personalized medicine.

Genetic Diversity of HLA Class I and Class II Alleles in Thai Populations: Contribution to Genotype-Guided Therapeutics

W. Aekplakorn, Chumpol Ngamphiw, S. Tongsima, 2020, Frontiers in Pharmacology.

Association of CETP Gene Variants with Atherogenic Dyslipidemia Among Thai Patients Treated with Statin

C. Sukasem, M. Kroll, C. Dejthevaporn, 2021, Pharmacogenomics and Personalized Medicine.

Effect of 5‐HT2C receptor gene polymorphism (HTR2C−759C/T) on metabolic adverse effects in Thai psychiatric patients treated with risperidone

C. Sukasem, A. Puangpetch, Natchaya Vanwong, 2021, Pharmacoepidemiology and drug safety.

Associations of the SREBF2 Gene and INSIG2 Polymorphisms with Obesity and Dyslipidemia in Thai Psychotic Disorder Patients Treated with Risperidone

C. Sukasem, A. Puangpetch, Natchaya Vanwong, 2021, Journal of personalized medicine.